Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 7Hematologic Neoplasms 7Graft vs Host Disease 5Gliosarcoma 5Glioblastoma 5Brain Neoplasms 5Prostatic Neoplasms 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Oligodendroglioma 2Neurofibrosarcoma 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Glioma 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2

Interventions

Peripheral Blood Stem Cell Transplantation 5Cyclophosphamide 5romidepsin 4pembrolizumab 4Lenalidomide 4Etoposide 410-propargyl-10-deazaaminopterin 4Rituximab 3fludarabine phosphate 2fludarabine 2durvalumab 2carmustine, poliferprosan 20 drug combination 2Vincristine 2Prednisone 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Melphalan 2Gemcitabine 2Doxorubicin 2Depsipeptides 2Cytarabine 2Carmustine 2Bendamustine Hydrochloride 2AFM13 2veliparib 1thymoglobulin 1tenalisib 1temsirolimus 1prednylidene 1mogamulizumab 1forodesine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphoma, T-Cell × Sirolimus × Clear all
NCT01076543 2019-10-16

Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

National Cancer Institute (NCI)

Phase 1/2 Completed
110 enrolled 17 charts
Lymphoid

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡